1
|
Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R, Obacz J, Papadodima O, Jouan F, Bourien H, Logotheti M, Jégou G, Pallares‐Lupon N, Schmit K, Le Reste P, Etcheverry A, Mosser J, Barroso K, Vauléon E, Maurel M, Samali A, Patterson JB, Pluquet O, Hetz C, Quillien V, Chatziioannou A, Chevet E. Dual IRE1 RNase functions dictate glioblastoma development. EMBO Mol Med 2023; 15:e16731. [PMID: 36752056 PMCID: PMC9906329 DOI: 10.15252/emmm.202216731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2022] [Accepted: 12/06/2022] [Indexed: 02/09/2023] Open
|
2
|
Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R, Obacz J, Papadodima O, Jouan F, Bourien H, Logotheti M, Jégou G, Pallares-Lupon N, Schmit K, Le Reste PJ, Etcheverry A, Mosser J, Barroso K, Vauléon E, Maurel M, Samali A, Patterson JB, Pluquet O, Hetz C, Quillien V, Chatziioannou A, Chevet E. Dual IRE1 RNase functions dictate glioblastoma development. EMBO Mol Med 2022; 14:e15622. [PMID: 35014200 DOI: 10.15252/emmm.202115622] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2021] [Accepted: 12/21/2021] [Indexed: 11/09/2022] Open
|
3
|
Martin S, Heslan C, Jégou G, Eriksson LA, Le Gallo M, Thibault V, Chevet E, Godey F, Avril T. SARS-CoV-2 integral membrane proteins shape the serological responses of patients with COVID-19. iScience 2021; 24:103185. [PMID: 34604721 PMCID: PMC8479324 DOI: 10.1016/j.isci.2021.103185] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Revised: 08/16/2021] [Accepted: 09/24/2021] [Indexed: 12/23/2022] Open
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has elicited a unique mobilization of the scientific community to develop efficient tools to understand and combat the infection. Like other coronavirae, SARS-CoV-2 hijacks host cell secretory machinery to produce viral proteins that compose the nascent virions; including spike (S), envelope (E), and membrane (M) proteins, the most exposed transmembrane proteins to the host immune system. As antibody response is part of the anti-viral immune arsenal, we investigate the immunogenic potential of S, E, and M using a human cell-based system to mimic membrane insertion and N-glycosylation. Both S and M elicit specific Ig production in patients with SARS-CoV-2. Patients with moderate and severe diseases exhibit elevated Ig responses. Finally, reduced Ig binding was observed with spike G614 compared to D614 variant. Altogether, our assay points toward an unexpected immune response against M and represents a powerful tool to test humoral responses against actively evolving SARS-CoV-2 variants and vaccine effectiveness.
Collapse
Affiliation(s)
- Sophie Martin
- Inserm U1242 Oncogenesis Stress Signaling, 35000 Rennes, France
- Centre Eugène Marquis, 35000 Rennes, France
| | | | - Gwénaële Jégou
- Inserm U1242 Oncogenesis Stress Signaling, 35000 Rennes, France
- Centre Eugène Marquis, 35000 Rennes, France
| | - Leif A. Eriksson
- Department of Chemistry & Molecular Biology, University of Gothenburg, 41390 Göteborg, Sweden
| | - Matthieu Le Gallo
- Inserm U1242 Oncogenesis Stress Signaling, 35000 Rennes, France
- Centre Eugène Marquis, 35000 Rennes, France
| | | | - Eric Chevet
- Inserm U1242 Oncogenesis Stress Signaling, 35000 Rennes, France
- Centre Eugène Marquis, 35000 Rennes, France
| | - Florence Godey
- Inserm U1242 Oncogenesis Stress Signaling, 35000 Rennes, France
- Centre Eugène Marquis, 35000 Rennes, France
| | - Tony Avril
- Inserm U1242 Oncogenesis Stress Signaling, 35000 Rennes, France
- Centre Eugène Marquis, 35000 Rennes, France
| |
Collapse
|
4
|
Le Reste PJ, Pineau R, Voutetakis K, Samal J, Jégou G, Lhomond S, Gorman AM, Samali A, Patterson JB, Zeng Q, Pandit A, Aubry M, Soriano N, Etcheverry A, Chatziioannou A, Mosser J, Avril T, Chevet E. Local intracerebral inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation/chemotherapy in vivo. Cancer Lett 2020; 494:73-83. [PMID: 32882336 DOI: 10.1016/j.canlet.2020.08.028] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2020] [Revised: 08/11/2020] [Accepted: 08/20/2020] [Indexed: 01/07/2023]
Abstract
Glioblastoma multiforme (GBM) is the most severe primary brain cancer. Despite an aggressive treatment comprising surgical resection and radio/chemotherapy, patient's survival post diagnosis remains short. A limitation for success in finding novel improved therapeutic options for such dismal disease partly lies in the lack of a relevant animal model that accurately recapitulates patient disease and standard of care. In the present study, we have developed an immunocompetent GBM model that includes tumor surgery and a radio/chemotherapy regimen resembling the Stupp protocol and we have used this model to test the impact of the pharmacological inhibition of the endoplasmic reticulum (ER) stress sensor IRE1, on treatment efficacy.
Collapse
Affiliation(s)
- Pierre Jean Le Reste
- Inserm U1242, University of Rennes, Rennes, France; Centre de lutte contre le cancer Eugène Marquis, Rennes, France; Rennes Brain Cancer Team (REACT), 35000, Rennes, France; Neurosurgery Dept, University Hospital of Rennes, 35000, Rennes, France
| | - Raphael Pineau
- Inserm U1242, University of Rennes, Rennes, France; Centre de lutte contre le cancer Eugène Marquis, Rennes, France; Rennes Brain Cancer Team (REACT), 35000, Rennes, France
| | - Konstantinos Voutetakis
- Institute of Chemical Biology, National Hellenic Research Foundation (N.H.R.F.), Athens, Greece; Department of Biochemistry and Biotechnology, University of Thessaly, Viopolis, 41500, Larissa, Greece
| | - Juhi Samal
- CÚRAM, Centre for Research in Medical Devices, National University of Ireland, Galway, Ireland
| | - Gwénaële Jégou
- Inserm U1242, University of Rennes, Rennes, France; Centre de lutte contre le cancer Eugène Marquis, Rennes, France; Rennes Brain Cancer Team (REACT), 35000, Rennes, France
| | - Stéphanie Lhomond
- CÚRAM, Centre for Research in Medical Devices, National University of Ireland, Galway, Ireland; Apoptosis Research Centre, National University Ireland Galway, Galway, Ireland
| | - Adrienne M Gorman
- CÚRAM, Centre for Research in Medical Devices, National University of Ireland, Galway, Ireland; Apoptosis Research Centre, National University Ireland Galway, Galway, Ireland
| | - Afshin Samali
- Apoptosis Research Centre, National University Ireland Galway, Galway, Ireland
| | - John B Patterson
- Fosun OrinovePharmaTech Inc., 3537 Old Conejo Road, Suite 104, Newbury Park, CA, 91320, USA
| | - Qingping Zeng
- Fosun OrinovePharmaTech Inc., 3537 Old Conejo Road, Suite 104, Newbury Park, CA, 91320, USA
| | - Abhay Pandit
- CÚRAM, Centre for Research in Medical Devices, National University of Ireland, Galway, Ireland
| | - Marc Aubry
- Rennes Brain Cancer Team (REACT), 35000, Rennes, France; University of Rennes, CNRS, IGDR [(Institut de Génétique et développement de Rennes)]-UMR 6290, F-35000, Rennes, France; CHU Rennes, Service de Génétique Moléculaire et Génomique Médicale, Rennes, France
| | - Nicolas Soriano
- Rennes Brain Cancer Team (REACT), 35000, Rennes, France; University of Rennes, CNRS, IGDR [(Institut de Génétique et développement de Rennes)]-UMR 6290, F-35000, Rennes, France
| | - Amandine Etcheverry
- CHU Rennes, Service de Génétique Moléculaire et Génomique Médicale, Rennes, France
| | - Aristotelis Chatziioannou
- Institute of Chemical Biology, National Hellenic Research Foundation (N.H.R.F.), Athens, Greece; e-NIOS PC, Kallithea-Athens, Greece
| | - Jean Mosser
- Rennes Brain Cancer Team (REACT), 35000, Rennes, France; University of Rennes, CNRS, IGDR [(Institut de Génétique et développement de Rennes)]-UMR 6290, F-35000, Rennes, France; CHU Rennes, Service de Génétique Moléculaire et Génomique Médicale, Rennes, France; University of Rennes, Plateforme GEH, CNRS, Inserm, BIOSIT - UMS 3480, US_S 018, F-35000, Rennes, France
| | - Tony Avril
- Inserm U1242, University of Rennes, Rennes, France; Centre de lutte contre le cancer Eugène Marquis, Rennes, France; Rennes Brain Cancer Team (REACT), 35000, Rennes, France
| | - Eric Chevet
- Inserm U1242, University of Rennes, Rennes, France; Centre de lutte contre le cancer Eugène Marquis, Rennes, France; Rennes Brain Cancer Team (REACT), 35000, Rennes, France.
| |
Collapse
|
5
|
Papaioannou A, Higa A, Jégou G, Jouan F, Pineau R, Saas L, Avril T, Pluquet O, Chevet E. Alterations of
EDEM
1 functions enhance
ATF
6 pro‐survival signaling. FEBS J 2018; 285:4146-4164. [DOI: 10.1111/febs.14669] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2017] [Revised: 08/31/2018] [Accepted: 09/28/2018] [Indexed: 12/17/2022]
Affiliation(s)
- Alexandra Papaioannou
- INSERM U1242 Université de Rennes France
- Centre de Lutte Contre le Cancer Eugène Marquis Rennes France
| | - Arisa Higa
- INSERM U1242 Université de Rennes France
| | - Gwénaële Jégou
- INSERM U1242 Université de Rennes France
- Centre de Lutte Contre le Cancer Eugène Marquis Rennes France
| | - Florence Jouan
- INSERM U1242 Université de Rennes France
- Centre de Lutte Contre le Cancer Eugène Marquis Rennes France
| | - Raphael Pineau
- INSERM U1242 Université de Rennes France
- Centre de Lutte Contre le Cancer Eugène Marquis Rennes France
| | - Laure Saas
- CNRS Institut Pasteur de Lille UMR8161 – M3T – Mechanisms of Tumorigenesis and Targeted Therapies Univ. Lille France
| | - Tony Avril
- INSERM U1242 Université de Rennes France
- Centre de Lutte Contre le Cancer Eugène Marquis Rennes France
| | - Olivier Pluquet
- CNRS Institut Pasteur de Lille UMR8161 – M3T – Mechanisms of Tumorigenesis and Targeted Therapies Univ. Lille France
| | - Eric Chevet
- INSERM U1242 Université de Rennes France
- Centre de Lutte Contre le Cancer Eugène Marquis Rennes France
- CNRS Institut Pasteur de Lille UMR8161 – M3T – Mechanisms of Tumorigenesis and Targeted Therapies Univ. Lille France
| |
Collapse
|
6
|
Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R, Obacz J, Papadodima O, Jouan F, Bourien H, Logotheti M, Jégou G, Pallares‐Lupon N, Schmit K, Le Reste P, Etcheverry A, Mosser J, Barroso K, Vauléon E, Maurel M, Samali A, Patterson JB, Pluquet O, Hetz C, Quillien V, Chatziioannou A, Chevet E. Dual IRE1 RNase functions dictate glioblastoma development. EMBO Mol Med 2018; 10:emmm.201707929. [PMID: 29311133 PMCID: PMC5840541 DOI: 10.15252/emmm.201707929] [Citation(s) in RCA: 111] [Impact Index Per Article: 18.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Proteostasis imbalance is emerging as a major hallmark of cancer, driving tumor aggressiveness. Evidence suggests that the endoplasmic reticulum (ER), a major site for protein folding and quality control, plays a critical role in cancer development. This concept is valid in glioblastoma multiform (GBM), the most lethal primary brain cancer with no effective treatment. We previously demonstrated that the ER stress sensor IRE1α (referred to as IRE1) contributes to GBM progression, through XBP1 mRNA splicing and regulated IRE1-dependent decay (RIDD) of RNA Here, we first demonstrated IRE1 signaling significance to human GBM and defined specific IRE1-dependent gene expression signatures that were confronted to human GBM transcriptomes. This approach allowed us to demonstrate the antagonistic roles of XBP1 mRNA splicing and RIDD on tumor outcomes, mainly through selective remodeling of the tumor stroma. This study provides the first demonstration of a dual role of IRE1 downstream signaling in cancer and opens a new therapeutic window to abrogate tumor progression.
Collapse
Affiliation(s)
| | - Tony Avril
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance
| | | | - Konstantinos Voutetakis
- Institute of Biology, Medicinal Chemistry & BiotechnologyNHRFAthensGreece,Department of Biochemistry & BiotechnologyUniversity of ThessalyLarissaGreece
| | - Dimitrios Doultsinos
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance
| | - Mari McMahon
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance,Apoptosis Research CentreSchool of Natural SciencesNUI GalwayGalwayIreland
| | - Raphaël Pineau
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance
| | - Joanna Obacz
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance
| | - Olga Papadodima
- Institute of Biology, Medicinal Chemistry & BiotechnologyNHRFAthensGreece
| | - Florence Jouan
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance
| | - Heloise Bourien
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance
| | - Marianthi Logotheti
- Institute of Biology, Medicinal Chemistry & BiotechnologyNHRFAthensGreece,e‐NIOS PCKallithea‐AthensGreece
| | - Gwénaële Jégou
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance
| | | | | | - Pierre‐Jean Le Reste
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Department of NeurosurgeryUniversity Hospital PontchaillouRennesFrance
| | - Amandine Etcheverry
- Integrated Functional Genomics and Biomarkers TeamUMR6290, CNRSUniversité de Rennes 1RennesFrance
| | - Jean Mosser
- Integrated Functional Genomics and Biomarkers TeamUMR6290, CNRSUniversité de Rennes 1RennesFrance
| | - Kim Barroso
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance
| | - Elodie Vauléon
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance
| | - Marion Maurel
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance,Apoptosis Research CentreSchool of Natural SciencesNUI GalwayGalwayIreland
| | - Afshin Samali
- Apoptosis Research CentreSchool of Natural SciencesNUI GalwayGalwayIreland
| | | | - Olivier Pluquet
- Institut Pasteur de LilleCNRS UMR8161 “Mechanisms of Tumourigenesis and Targeted Therapies”Université de LilleLilleFrance
| | - Claudio Hetz
- Biomedical Neuroscience InstituteFaculty of MedicineUniversity of ChileSantiagoChile,Program of Cellular and Molecular BiologyInstitute of Biomedical SciencesUniversity of ChileSantiagoChile,Center for Geroscience, Brain Health and MetabolismSantiagoChile,Buck Institute for Research on AgingNovatoCAUSA,Department of Immunology and Infectious diseasesHarvard School of Public HealthBostonMAUSA
| | - Véronique Quillien
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance
| | - Aristotelis Chatziioannou
- Institute of Biology, Medicinal Chemistry & BiotechnologyNHRFAthensGreece,e‐NIOS PCKallithea‐AthensGreece
| | - Eric Chevet
- INSERM U1242, “Chemistry, Oncogenesis, Stress, Signaling”Université de Rennes 1RennesFrance,Centre de Lutte Contre le Cancer Eugène MarquisRennesFrance
| |
Collapse
|